Roche Holding AG, in collaboration with Flatiron Health and Pfizer, has announced the presentation of new research at the upcoming ISPOR Europe 2025 Conference, scheduled for November 9-12 in Glasgow, Scotland, UK. The research includes a Top 5% Award Poster assessing the transportability of survival outcomes between the US and Austria, highlighting the challenges of applying real-world evidence across different healthcare settings. Results from this and other studies will be presented at the conference. In total, Flatiron's real-world data will be featured in more than 18 research presentations, including two Top 5% Award acceptances and ten other Flatiron-authored abstracts.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roche Holding AG published the original content used to generate this news brief via Business Wire (Ref. ID: 20251023007694) on October 23, 2025, and is solely responsible for the information contained therein.